Cargando…

Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis

BACKGROUND: Portal/hepatic vein tumor thrombosis (PVTT/HVTT) in hepatocellular carcinoma (HCC) is a sign of advanced stage disease and is associated with poor prognosis. This study investigated the surgical outcomes of patients with HCC and PVTT/HVTT to determine the most appropriate surgical treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaohua, Li, Qiaoxuan, Wang, Peng, Sun, Qing, Li, Zhongyuan, Yang, Ming, Shi, Wei, Wei, Rongping, Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468137/
https://www.ncbi.nlm.nih.gov/pubmed/26076461
http://dx.doi.org/10.1371/journal.pone.0130021
_version_ 1782376447968542720
author Shaohua, Li
Qiaoxuan, Wang
Peng, Sun
Qing, Li
Zhongyuan, Yang
Ming, Shi
Wei, Wei
Rongping, Guo
author_facet Shaohua, Li
Qiaoxuan, Wang
Peng, Sun
Qing, Li
Zhongyuan, Yang
Ming, Shi
Wei, Wei
Rongping, Guo
author_sort Shaohua, Li
collection PubMed
description BACKGROUND: Portal/hepatic vein tumor thrombosis (PVTT/HVTT) in hepatocellular carcinoma (HCC) is a sign of advanced stage disease and is associated with poor prognosis. This study investigated the surgical outcomes of patients with HCC and PVTT/HVTT to determine the most appropriate surgical treatment strategy for these patients. MATERIALS AND METHODS: The study population included 77 HCC patients from January 2004 to June 2009 who underwent hepatectomy in our department and were diagnosed with PVTT/HVTT based on pathological examination. The patients were divided into two groups: in group 1, PVTT/HVTT was located in the hepatic resection area and removed with the tumor en bloc (38 cases); in group 2, PVTT/HVTT was beyond the resection line and removed by suction or thrombectomy (39 cases). Concerning the factor of surgical margins, the patients were further divided into four subgroups: group 1A: patients in group 1 with surgical margins ≤1 cm (28 cases); group 1B: patients in group 1 with surgical margins >1 cm (9 cases); group 2A: patients in group 2 with surgical margins ≤1 cm (28 cases); and group 2B: patients in group 2 with surgical margins >1 cm (9 cases). RESULTS: Most of the characteristics of groups 1 and 2 were similar. Patients in group 2 had significantly higher median blood loss (p=0.002) and higher blood transfusion rate (p=0.002) during the operation, which were not considered prognostic factors (p=0.323 and 0.571, respectively). The median overall survival (OS) duration in group 1 was significantly longer than that in group 2 (14.3 vs. 10.4 months, p=0.047). The median OS durations in groups 1A, 1B, 2A, and 2B were 14.3, 42.7, 7.5, and 18.0 months, respectively, which were significantly different(p=0.018). CONCLUSIONS: When PVTT/HVTT is located in the hepatic resection area and removed with the tumor en bloc, the median OS duration is longer. Based on this finding, widening the surgical margins when technically possible may increase OS.
format Online
Article
Text
id pubmed-4468137
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44681372015-06-25 Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis Shaohua, Li Qiaoxuan, Wang Peng, Sun Qing, Li Zhongyuan, Yang Ming, Shi Wei, Wei Rongping, Guo PLoS One Research Article BACKGROUND: Portal/hepatic vein tumor thrombosis (PVTT/HVTT) in hepatocellular carcinoma (HCC) is a sign of advanced stage disease and is associated with poor prognosis. This study investigated the surgical outcomes of patients with HCC and PVTT/HVTT to determine the most appropriate surgical treatment strategy for these patients. MATERIALS AND METHODS: The study population included 77 HCC patients from January 2004 to June 2009 who underwent hepatectomy in our department and were diagnosed with PVTT/HVTT based on pathological examination. The patients were divided into two groups: in group 1, PVTT/HVTT was located in the hepatic resection area and removed with the tumor en bloc (38 cases); in group 2, PVTT/HVTT was beyond the resection line and removed by suction or thrombectomy (39 cases). Concerning the factor of surgical margins, the patients were further divided into four subgroups: group 1A: patients in group 1 with surgical margins ≤1 cm (28 cases); group 1B: patients in group 1 with surgical margins >1 cm (9 cases); group 2A: patients in group 2 with surgical margins ≤1 cm (28 cases); and group 2B: patients in group 2 with surgical margins >1 cm (9 cases). RESULTS: Most of the characteristics of groups 1 and 2 were similar. Patients in group 2 had significantly higher median blood loss (p=0.002) and higher blood transfusion rate (p=0.002) during the operation, which were not considered prognostic factors (p=0.323 and 0.571, respectively). The median overall survival (OS) duration in group 1 was significantly longer than that in group 2 (14.3 vs. 10.4 months, p=0.047). The median OS durations in groups 1A, 1B, 2A, and 2B were 14.3, 42.7, 7.5, and 18.0 months, respectively, which were significantly different(p=0.018). CONCLUSIONS: When PVTT/HVTT is located in the hepatic resection area and removed with the tumor en bloc, the median OS duration is longer. Based on this finding, widening the surgical margins when technically possible may increase OS. Public Library of Science 2015-06-15 /pmc/articles/PMC4468137/ /pubmed/26076461 http://dx.doi.org/10.1371/journal.pone.0130021 Text en © 2015 Shaohua et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Shaohua, Li
Qiaoxuan, Wang
Peng, Sun
Qing, Li
Zhongyuan, Yang
Ming, Shi
Wei, Wei
Rongping, Guo
Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
title Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
title_full Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
title_fullStr Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
title_full_unstemmed Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
title_short Surgical Strategy for Hepatocellular Carcinoma Patients with Portal/Hepatic Vein Tumor Thrombosis
title_sort surgical strategy for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468137/
https://www.ncbi.nlm.nih.gov/pubmed/26076461
http://dx.doi.org/10.1371/journal.pone.0130021
work_keys_str_mv AT shaohuali surgicalstrategyforhepatocellularcarcinomapatientswithportalhepaticveintumorthrombosis
AT qiaoxuanwang surgicalstrategyforhepatocellularcarcinomapatientswithportalhepaticveintumorthrombosis
AT pengsun surgicalstrategyforhepatocellularcarcinomapatientswithportalhepaticveintumorthrombosis
AT qingli surgicalstrategyforhepatocellularcarcinomapatientswithportalhepaticveintumorthrombosis
AT zhongyuanyang surgicalstrategyforhepatocellularcarcinomapatientswithportalhepaticveintumorthrombosis
AT mingshi surgicalstrategyforhepatocellularcarcinomapatientswithportalhepaticveintumorthrombosis
AT weiwei surgicalstrategyforhepatocellularcarcinomapatientswithportalhepaticveintumorthrombosis
AT rongpingguo surgicalstrategyforhepatocellularcarcinomapatientswithportalhepaticveintumorthrombosis